Christopher Mason, Ph.D., explains how a new initiative funded by WorldQuant founder Igor Tulchinsky will help medical researchers make better predictions. Read more
John P. Leonard, M.D., discusses the emergence and potential of chimeric antigen receptor (CAR) T-cell therapy across hematologic malignancies. Read more
Using stem cells and three-dimensional organoids, Lukas Dow, Ph.D., and colleagues have created a colon cancer model that more accurately reflects the progression of the disease. Read more
Feature about Biotia, a startup offering microbial surveillance for hospitals, is a joint venture between Christopher Mason and colleagues at Cornell Tech. Read more
A survey of almost six million breast exams found not one case of untreated cancer had regressed by the next mammogram—refuting the notion that overdiagnosis could be reduced by delaying the starting age for mammography screening or increasing the interval between exams. Read more
Brain tumors recruit immune cells derived from bone marrow to transform what began as benign masses into deadly malignancies, according to studies led by Jeffrey Greenfield, M.D., Ph.D. Read more